Integrated ReportFiscal Year Ended Mar. 31, 2025
Top Management
Our Company
- Olympus’ Value Creation Model
- Our History
- At a Glance
- Our Business
- Overview and Direction of Three Focus Areas
Our Strategy
- Company Strategy and Progress
- Materiality Topics at Olympus
- Investments for Patient Safety and Our Future Growth
- Intelligent Endoscopy Ecosystem
- High Growth Potential Markets
- Efforts to Support Organic Growth through Inorganic Initiatives
Non-financial Capitals
- Innovation
- R&D Dialogue
- Intellectual Property Activities
- Evolving Our Corporate Culture
- Carbon Neutral Society and Circular Economy
- Responsible Supply Chain
Corporate Governance
Data
- Global Healthcare Data
- Financial/Non-financial Highlights
- 10-year Financial/Non-financial Data
- Corporate Information/Stock Information
- FY Ended Mar. 31, 2025
- FY Ended Mar. 31, 2024
- FY Ended Mar. 31, 2023
- FY Ended Mar. 31, 2022
- FY Ended Mar. 31, 2021
- FY Ended Mar. 31, 2020
- FY Ended Mar. 31, 2019
- FY Ended Mar. 31, 2018
- FY Ended Mar. 31, 2017
- FY Ended Mar. 31, 2016
- FY Ended Mar. 31, 2015
- FY Ended Mar. 31, 2014
- FY Ended Mar. 31, 2013
- FY Ended Mar. 31, 2012